The Dynamics of Interactions Among Immune and Glioblastoma Cells

Katalin Eder, B. Kálmán

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Glioblastoma is the most common intracranial malignancy that constitutes about 50 % of all gliomas. Despite aggressive, multimodal therapy consisting of surgery, radiation, and chemotherapy, the outcome of patients with glioblastoma remains poor with 5-year survival rates of

Original languageEnglish
Pages (from-to)335-352
Number of pages18
JournalNeuroMolecular Medicine
Volume17
Issue number4
DOIs
Publication statusPublished - Dec 1 2015

Fingerprint

Glioblastoma
Glioma
Survival Rate
Radiation
Drug Therapy
Neoplasms
Therapeutics

Keywords

  • Glioblastoma
  • Immune cells
  • Immune-based therapeutic strategies
  • Immunology
  • Tumor infiltration

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Molecular Medicine
  • Neurology

Cite this

The Dynamics of Interactions Among Immune and Glioblastoma Cells. / Eder, Katalin; Kálmán, B.

In: NeuroMolecular Medicine, Vol. 17, No. 4, 01.12.2015, p. 335-352.

Research output: Contribution to journalArticle

@article{0afee80690ba40a7a93fb2c7bc5fbf61,
title = "The Dynamics of Interactions Among Immune and Glioblastoma Cells",
abstract = "Glioblastoma is the most common intracranial malignancy that constitutes about 50 {\%} of all gliomas. Despite aggressive, multimodal therapy consisting of surgery, radiation, and chemotherapy, the outcome of patients with glioblastoma remains poor with 5-year survival rates of",
keywords = "Glioblastoma, Immune cells, Immune-based therapeutic strategies, Immunology, Tumor infiltration",
author = "Katalin Eder and B. K{\'a}lm{\'a}n",
year = "2015",
month = "12",
day = "1",
doi = "10.1007/s12017-015-8362-x",
language = "English",
volume = "17",
pages = "335--352",
journal = "NeuroMolecular Medicine",
issn = "1535-1084",
publisher = "Humana Press",
number = "4",

}

TY - JOUR

T1 - The Dynamics of Interactions Among Immune and Glioblastoma Cells

AU - Eder, Katalin

AU - Kálmán, B.

PY - 2015/12/1

Y1 - 2015/12/1

N2 - Glioblastoma is the most common intracranial malignancy that constitutes about 50 % of all gliomas. Despite aggressive, multimodal therapy consisting of surgery, radiation, and chemotherapy, the outcome of patients with glioblastoma remains poor with 5-year survival rates of

AB - Glioblastoma is the most common intracranial malignancy that constitutes about 50 % of all gliomas. Despite aggressive, multimodal therapy consisting of surgery, radiation, and chemotherapy, the outcome of patients with glioblastoma remains poor with 5-year survival rates of

KW - Glioblastoma

KW - Immune cells

KW - Immune-based therapeutic strategies

KW - Immunology

KW - Tumor infiltration

UR - http://www.scopus.com/inward/record.url?scp=84947125628&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84947125628&partnerID=8YFLogxK

U2 - 10.1007/s12017-015-8362-x

DO - 10.1007/s12017-015-8362-x

M3 - Article

VL - 17

SP - 335

EP - 352

JO - NeuroMolecular Medicine

JF - NeuroMolecular Medicine

SN - 1535-1084

IS - 4

ER -